Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 690, pseudogene (abbreviated as RN7SL690P) is a member of the large family of human pseudogenes related to the 7SL RNA component of the signal recognition particle (SRP)[1][6]. Pseudogenes like RN7SL690P are non-functional DNA segments that arose from reverse transcription and insertion of the 7SL RNA sequence back into the genome, resulting in truncated gene copies that lack functional regulatory or coding elements[1][6][4]. These pseudogenes do not produce functional RNA or protein, and there is no evidence that RN7SL690P acts as a receptor, enzyme, or any kind of therapeutic target. Most 7SL pseudogenes are considered evolutionary relics without established biological or disease roles[1][4][6]. Some 7SL RNA pseudogenes may occasionally function in gene regulation at the RNA level, but there is no direct evidence implicating RN7SL690P in any specific biological process or disease. It is not a drug target, biomarker, or known to have any safety or therapeutic concern. This entry is likely only relevant in the context of genome annotation as a non-coding, non-functional pseudogene[1][6][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 690, pseudogene (RN7SL690P).